Biolife Solutions (BLFS) Liabilities and Shareholders Equity (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $400.9 million in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 1.46% year-over-year to $400.9 million in Q1 2026; TTM through Mar 2026 was $1.6 billion, a 2.25% increase from a year earlier, with the FY2025 full-year figure at $405.9 million, up 1.6% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $400.9 million, down from $405.9 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for BLFS reached as high as $544.3 million in Q1 2022 and fell as low as $375.0 million in Q2 2024.
• Historically, Liabilities and Shareholders Equity has averaged $423.3 million across 5 years, with a median of $405.9 million in 2025.
• On a YoY basis, Liabilities and Shareholders Equity climbed as much as 126.76% in 2022 and fell as far as 18.77% in 2022.
• Year by year, Liabilities and Shareholders Equity stood at $450.2 million in 2022, then slipped by 8.33% to $412.7 million in 2023, then declined by 3.2% to $399.5 million in 2024, then climbed by 1.6% to $405.9 million in 2025, then decreased by 1.23% to $400.9 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $400.9 million in Q1 2026, $405.9 million in Q4 2025, and $392.1 million in Q3 2025.